LY 3000328 (Cathepsin S inhibitor) 是 Cathepsin S 的选择性抑制剂,抑制人和小鼠Cat S 的IC50分别为7.7,1.67 nM。LY 3000328 (Cathepsin S inhibitor)可以通过抑制 Cathepsin S 介导的细胞外基质蛋白、弹性蛋白和胶原蛋白的降解来减缓或阻止腹主动脉瘤 (AAA) 扩张和 或降低 AAA 破裂的风险。
Highly potent and selective group II metabotropic glutamate receptor antagonist. Disodium salt of LY 341495 Fitzjohn et al (1998) The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology 37 1445 PMID:9886667 |Ornstein et al (1998) 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl) glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioav J.Med.Chem. 41 358 PMID:9464367 |Johnson et al (1999) [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology 38 1519 PMID:10530814